FDA: Epilepsy Drugs Double Suicide Risk

Increased risk warrants change in prescribing guidelines, health officials say

WASHINGTON (Reuters) - U.S. health officials alerted doctors on Thursday that medicines used to treat epilepsy and psychiatric disorders may raise the risk of suicidal thoughts and behavior.

The Food and Drug Administration said it analyzed studies of 11 epilepsy drugs including Pfizer Inc's Neurontin, Abbott Laboratories Inc's Depakote and Johnson & Johnson's Topamax. The studies included nearly 44,000 patients.

Click on "related links" for the full article from ABC News.

Page: [[$index + 1]]